Need help finding what you are looking for?
Contact Us
PUBLISHER: 360iResearch | PRODUCT CODE: 2086075
PUBLISHER: 360iResearch | PRODUCT CODE: 2086075
MRI Guided Neurosurgical Ablation Market by Technology Type, Procedure Type, Procedure Objective, Application - Global Forecast 2026-2032
PUBLISHED:
PAGES: 197 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The MRI Guided Neurosurgical Ablation Market is projected to grow by USD 1,268.99 million at a CAGR of 8.29% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 726.60 million |
| Estimated Year [2026] | USD 785.53 million |
| Forecast Year [2032] | USD 1,268.99 million |
| CAGR (%) | 8.29% |
MRI guided neurosurgical ablation is redefining functional neurosurgery, neuro-oncology, and epilepsy care by combining stereotactic targeting with real-time magnetic resonance imaging and thermal monitoring. The field includes laser interstitial thermal therapy, often called LITT, and MRI guided focused ultrasound, both of which enable precise lesioning while reducing the need for large craniotomies in selected patients.
Demand is anchored in measurable clinical need. The World Health Organization reports that epilepsy affects around 50 million people worldwide, Parkinson disease affected more than 8.5 million people in 2019, and GLOBOCAN 2022 recorded more than 300,000 new brain and central nervous system cancer cases globally. These disease burdens support sustained interest in minimally invasive neurosurgical ablation technologies that can improve procedural precision, recovery profiles, and care pathways for complex neurological conditions.
Transformative Shifts in the Neurosurgical Ablation Landscape
The landscape is shifting from exposure-heavy neurosurgery toward image-guided, incision-sparing intervention. MRI thermometry allows clinicians to visualize temperature changes during ablation, improving procedural control and supporting protection of eloquent brain structures. This capability is especially important in deep-seated lesions, drug-resistant epilepsy foci, tremor pathways, and movement disorder targets where millimetric accuracy is critical.
Adoption is also being shaped by higher-field MRI availability, stereotactic robotics, improved laser fiber and transducer designs, and hospital priorities around shorter recovery times. Payers and health systems are increasingly evaluating ablation through measurable outcomes such as seizure reduction, tremor control, length of stay, complication rates, neurocognitive preservation, and retreatment requirements.
Cumulative Impact of Artificial Intelligence
Artificial intelligence is beginning to influence every phase of MRI guided neurosurgical ablation, from patient selection to treatment planning and post-procedure surveillance. AI-enabled segmentation can help identify lesion boundaries, vascular structures, white matter tracts, and thermal-risk zones, while predictive models may support trajectory planning, ablation-volume estimation, and follow-up imaging assessment.
The impact is cumulative rather than isolated. As the U.S. Food and Drug Administration list of AI and machine learning-enabled medical devices has expanded rapidly, with radiology representing the largest category, neurosurgical teams are gaining access to increasingly mature image-analysis tools. However, clinical adoption depends on validation, explainability, cybersecurity, workflow integration, and evidence that AI improves safety, reproducibility, or patient outcomes in MRI guided neurosurgical ablation.
Key Regional Insights Across Major Markets
North America remains a leading region for MRI guided neurosurgical ablation due to advanced hospital infrastructure, high MRI capacity, active academic neurosurgery programs, and established regulatory pathways for technologies such as LITT platforms and MRI guided focused ultrasound systems. The United States anchors regional adoption through specialized epilepsy, neuro-oncology, and movement disorder centers, while Canada supports evidence-based use within publicly funded care models.
Europe shows strong adoption potential through specialized neurosurgical centers, robust clinical research networks, and broad access to advanced neuroimaging; however, implementation is influenced by EU Medical Device Regulation requirements, reimbursement variability, and health technology assessment standards. Asia-Pacific is gaining momentum as Japan, China, South Korea, India, and Australia expand advanced imaging, oncology, epilepsy, and movement disorder programs, supported by rising investment in tertiary neuroscience infrastructure. Latin America is developing through private tertiary hospitals and major academic centers in Brazil and Mexico, although access remains uneven across public systems and rural populations. The Middle East, particularly high-income Gulf countries, is investing in high-acuity neuroscience infrastructure and medical travel retention, while Africa faces MRI access constraints that make regional centers of excellence essential for broader availability of MRI guided neurosurgical ablation.
Key Group Insights for Strategic Market Positioning
Across ASEAN, growth is supported by expanding private hospitals, medical tourism, and neurosurgical modernization in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, although procedure availability depends on trained specialists, MRI capacity, and referral pathways. The GCC is positioned as a premium adoption cluster because national health strategies in Saudi Arabia, the United Arab Emirates, Qatar, and neighboring markets prioritize advanced tertiary care, neuroscience centers, and reduced outbound medical travel.
The European Union offers a large, highly regulated clinical environment with strong research networks, cross-border evidence generation, and centralized procurement in many health systems, while BRICS countries combine substantial neurological disease burden and large patient populations with uneven infrastructure and reimbursement maturity. G7 markets generally lead in clinical evidence generation, reimbursement assessment, regulatory oversight, and academic adoption of MRI guided neurosurgical ablation. NATO countries benefit from advanced hospital systems, technology interoperability, and established neuroscience research capacity, particularly where trauma, rehabilitation, and complex neurosurgical services strengthen broader neurological care ecosystems.
Key Country Insights in MRI Guided Neurosurgical Ablation
The United States leads commercialization through academic medical centers, private hospital systems, FDA-cleared platforms, and high procedural specialization across epilepsy surgery, neuro-oncology, and functional neurosurgery, while Canada emphasizes evidence-based adoption within publicly funded care. Mexico and Brazil show growing demand in major urban centers, particularly where private insurers, specialist hospitals, and tertiary academic institutions support advanced neurosurgical procedures.
In Europe, the United Kingdom, Germany, France, Italy, and Spain combine sophisticated neuroimaging, established neurosurgical training, and strong clinical research capacity, while Russia has selective adoption through major federal and urban centers with advanced imaging infrastructure. China is scaling advanced neurosurgery rapidly through large hospital networks and expanding MRI capacity, India has high unmet neurological need and expanding private-sector capability, Japan and South Korea benefit from technology-intensive healthcare systems and strong imaging infrastructure, and Australia supports adoption through specialized centers serving a geographically dispersed population with complex referral needs.
Actionable Recommendations for Industry Leaders
Industry leaders should prioritize clinical evidence that compares MRI guided neurosurgical ablation with open surgery, radiosurgery, deep brain stimulation, and medical management for well-defined indications. Evidence packages should include seizure outcomes, tremor scores, tumor control indicators where relevant, length of stay, neurocognitive outcomes, adverse events, patient-reported outcomes, and total cost of care.
Commercial strategy should focus on multidisciplinary centers that combine neurosurgery, neuroradiology, epilepsy monitoring, neuro-oncology, radiation oncology, and movement disorder expertise. Technology developers and service providers should also invest in physician training, MRI compatibility support, service uptime, reimbursement dossiers, AI validation, cybersecurity readiness, and patient-selection tools that help hospitals build safe, repeatable MRI guided neurosurgical ablation programs.
Research Methodology
This executive summary is developed using a structured secondary research approach. Inputs include peer-reviewed neurosurgery and neuroradiology literature, regulatory databases, publicly available device-clearance information, hospital adoption patterns, disease-burden data from the World Health Organization and GLOBOCAN, and policy context from regional health authorities.
Insights are triangulated across clinical evidence, technology readiness, reimbursement dynamics, regulatory context, and infrastructure indicators such as MRI availability and tertiary neurosurgery capacity. The methodology avoids unsupported market-size claims and emphasizes verified trends, documented disease burden, regulatory status, clinical-use patterns, and observable adoption drivers across regions, economic groups, and major countries.
Conclusion
MRI guided neurosurgical ablation is moving from specialized innovation to a strategic capability in advanced neuroscience care. Its value proposition is strongest where precise targeting, real-time thermal feedback, shorter recovery, and reduced surgical exposure align with clinical needs in epilepsy, brain tumors, and movement disorders.
Future progress will depend on evidence quality, reimbursement confidence, center-level expertise, MRI access, and integration with AI-enabled imaging workflows. Organizations that combine clinically validated technology, disciplined training, regional access strategies, and outcome-driven commercialization will be best positioned in the evolving MRI guided neurosurgical ablation landscape.
Product Code: MRR-036C5CF3A877
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. MRI Guided Neurosurgical Ablation Market, by Technology Type
- 7.1. MRI-Guided Laser Ablation
- 7.2. MRI-Guided Radiofrequency (RF) Ablation
- 7.3. MRI-Guided Focused Ultrasound
8. MRI Guided Neurosurgical Ablation Market, by Procedure Type
- 8.1. Minimally Invasive Procedures
- 8.2. Non-Invasive Procedures
9. MRI Guided Neurosurgical Ablation Market, by Procedure Objective
- 9.1. Curative Procedures
- 9.2. Palliative Procedures
- 9.3. Functional Modulation Procedures
10. MRI Guided Neurosurgical Ablation Market, by Application
- 10.1. Brain Tumors
- 10.1.1. Glioblastoma
- 10.1.2. Meningioma
- 10.1.3. Metastatic Tumors
- 10.2. Chronic Pain
- 10.2.1. Sciatica
- 10.2.2. Trigeminal Neuralgia
- 10.3. Epilepsy
- 10.3.1. Focal Epilepsy
- 10.3.2. Temporal Lobe Epilepsy
- 10.4. Movement Disorders
- 10.4.1. Dystonia
- 10.4.2. Essential Tremor
- 10.4.3. Parkinson's Disease
11. MRI Guided Neurosurgical Ablation Market, by Region
- 11.1. Asia-Pacific
- 11.2. North America
- 11.3. Latin America
- 11.4. Europe
- 11.5. Middle East
- 11.6. Africa
12. MRI Guided Neurosurgical Ablation Market, by Group
- 12.1. ASEAN
- 12.2. GCC
- 12.3. European Union
- 12.4. BRICS
- 12.5. G7
- 12.6. NATO
13. MRI Guided Neurosurgical Ablation Market, by Country
- 13.1. United States
- 13.2. Canada
- 13.3. Mexico
- 13.4. Brazil
- 13.5. United Kingdom
- 13.6. Germany
- 13.7. France
- 13.8. Russia
- 13.9. Italy
- 13.10. Spain
- 13.11. China
- 13.12. India
- 13.13. Japan
- 13.14. Australia
- 13.15. South Korea
14. Competitive Landscape
- 14.1. Market Concentration Analysis, 2025
- 14.1.1. Concentration Ratio (CR)
- 14.1.2. Herfindahl Hirschman Index (HHI)
- 14.2. Recent Developments & Impact Analysis, 2025
- 14.3. Product Portfolio Analysis, 2025
- 14.4. Benchmarking Analysis, 2025
15. Company Profiles
- 15.1. Accuray Incorporated
- 15.2. AngioDynamics, Inc.
- 15.3. Boston Scientific Corporation
- 15.4. ClearPoint Neuro, Inc.
- 15.5. Elekta AB
- 15.6. Insightec Ltd.
- 15.7. Medtronic plc
- 15.8. Monteris Medical Inc.
- 15.9. Profound Medical Corp.
- 15.10. Siemens Healthineers AG
Product Code: MRR-036C5CF3A877
LIST OF FIGURES
- FIGURE 1. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, YEARS CONSIDERED FOR THE STUDY
- FIGURE 2. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, RESEARCH DESIGN
- FIGURE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, RESEARCH FRAMEWORK
- FIGURE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, DATA TRIANGULATION
- FIGURE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- FIGURE 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2025
- FIGURE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONING MATRIX, 2025
- FIGURE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
- FIGURE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
- FIGURE 10. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
- FIGURE 11. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
- FIGURE 12. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2025 VS 2032 (%)
- FIGURE 13. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2025 VS 2026 VS 2032 (USD MILLION)
- FIGURE 14. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
- FIGURE 15. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
- FIGURE 16. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
- FIGURE 17. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
- FIGURE 18. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
- FIGURE 19. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
- FIGURE 20. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
- FIGURE 21. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
LIST OF TABLES
- TABLE 1. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 2. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 3. GLOBAL MRI-GUIDED LASER ABLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 4. GLOBAL MRI-GUIDED LASER ABLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 5. GLOBAL MRI-GUIDED LASER ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 6. GLOBAL MRI-GUIDED RADIOFREQUENCY (RF) ABLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 7. GLOBAL MRI-GUIDED RADIOFREQUENCY (RF) ABLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 8. GLOBAL MRI-GUIDED RADIOFREQUENCY (RF) ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 9. GLOBAL MRI-GUIDED FOCUSED ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 10. GLOBAL MRI-GUIDED FOCUSED ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 11. GLOBAL MRI-GUIDED FOCUSED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 12. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 13. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 14. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 15. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 16. GLOBAL NON-INVASIVE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 17. GLOBAL NON-INVASIVE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 18. GLOBAL NON-INVASIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 19. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 20. GLOBAL CURATIVE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 21. GLOBAL CURATIVE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 22. GLOBAL CURATIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 23. GLOBAL PALLIATIVE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 24. GLOBAL PALLIATIVE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 25. GLOBAL PALLIATIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 26. GLOBAL FUNCTIONAL MODULATION PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 27. GLOBAL FUNCTIONAL MODULATION PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 28. GLOBAL FUNCTIONAL MODULATION PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 29. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 30. GLOBAL BRAIN TUMORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 31. GLOBAL BRAIN TUMORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 32. GLOBAL BRAIN TUMORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 33. GLOBAL GLIOBLASTOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 34. GLOBAL GLIOBLASTOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 35. GLOBAL GLIOBLASTOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 36. GLOBAL MENINGIOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 37. GLOBAL MENINGIOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 38. GLOBAL MENINGIOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 39. GLOBAL METASTATIC TUMORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 40. GLOBAL METASTATIC TUMORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 41. GLOBAL METASTATIC TUMORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 42. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 43. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 44. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 45. GLOBAL SCIATICA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 46. GLOBAL SCIATICA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 47. GLOBAL SCIATICA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 48. GLOBAL TRIGEMINAL NEURALGIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 49. GLOBAL TRIGEMINAL NEURALGIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 50. GLOBAL TRIGEMINAL NEURALGIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 51. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 52. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 53. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 54. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 55. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 56. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 57. GLOBAL TEMPORAL LOBE EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 58. GLOBAL TEMPORAL LOBE EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 59. GLOBAL TEMPORAL LOBE EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 60. GLOBAL MOVEMENT DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 61. GLOBAL MOVEMENT DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 62. GLOBAL MOVEMENT DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 63. GLOBAL DYSTONIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 64. GLOBAL DYSTONIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 65. GLOBAL DYSTONIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 66. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 67. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 68. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 69. GLOBAL PARKINSON'S DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 70. GLOBAL PARKINSON'S DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 71. GLOBAL PARKINSON'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 72. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
- TABLE 73. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 74. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 75. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 76. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 77. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 78. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 79. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 80. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 81. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 82. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 83. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 84. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 85. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 86. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 87. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 88. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 89. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 90. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 91. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 92. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 93. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 94. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 95. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 96. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 97. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 98. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 99. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 100. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 101. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 102. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 103. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 104. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 105. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 106. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 107. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 108. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 109. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 110. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 111. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 112. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 113. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 114. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 115. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 116. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 117. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 118. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 119. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 120. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 121. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 122. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 123. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 124. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 125. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 126. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 127. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
- TABLE 128. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 129. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 130. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 131. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 132. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 133. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 134. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 135. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 136. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 137. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 138. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 139. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 140. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 141. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 142. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 143. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 144. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 145. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 146. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 147. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 148. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 149. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 150. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 151. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 152. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 153. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 154. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 155. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 156. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 157. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 158. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 159. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 160. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 161. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 162. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 163. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 164. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 165. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 166. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 167. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 168. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 169. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 170. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 171. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 172. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 173. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 174. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 175. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 176. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 177. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 178. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 179. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 180. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 181. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 182. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
- TABLE 183. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 184. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 185. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 186. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 187. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 188. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 189. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 190. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 191. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 192. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 193. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 194. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 195. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 196. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 197. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 198. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 199. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 200. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 201. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 202. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 203. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 204. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 205. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 206. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 207. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 208. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 209. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 210. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 211. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 212. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 213. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 214. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 215. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 216. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 217. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 218. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 219. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 220. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 221. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 222. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 223. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 224. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 225. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 226. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 227. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 228. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 229. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 230. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 231. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 232. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 233. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 234. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 235. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 236. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 237. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 238. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 239. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 240. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 241. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 242. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 243. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 244. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 245. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 246. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 247. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 248. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 249. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 250. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 251. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 252. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 253. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 254. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 255. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 256. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 257. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 258. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 259. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 260. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 261. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 262. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 263. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 264. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 265. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 266. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 267. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 268. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 269. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 270. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 271. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 272. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 273. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 274. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 275. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 276. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 277. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 278. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 279. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 280. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 281. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 282. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 283. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 284. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 285. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 286. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 287. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 288. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 289. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 290. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 291. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 292. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 293. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 294. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 295. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 296. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 297. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 298. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 299. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 300. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 301. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 302. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 303. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 304. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 305. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 306. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 307. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 308. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
- TABLE 309. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
- TABLE 310. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
- TABLE 311. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
- TABLE 312. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2018-2032 (USD MILLION)
- TABLE 313. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
- TABLE 314. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
- TABLE 315. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
- TABLE 316. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
- TABLE 317. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.